Page last updated: 2024-10-30

lansoprazole and Gastrointestinal Stromal Neoplasm

lansoprazole has been researched along with Gastrointestinal Stromal Neoplasm in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Research Excerpts

ExcerptRelevanceReference
"After 2 months of treatment with imatinib 400 mg/day, a 60-year-old white female affected by GIST developed bilateral palpebral edema with hyperemic conjunctivae and labial edema when lansoprazole 15 mg/day was introduced to treat dyspeptic symptomatology."7.73Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. ( Ardau, R; Chillotti, C; De Lisa, R; Del Zompo, M; Severino, G, 2005)
"After 2 months of treatment with imatinib 400 mg/day, a 60-year-old white female affected by GIST developed bilateral palpebral edema with hyperemic conjunctivae and labial edema when lansoprazole 15 mg/day was introduced to treat dyspeptic symptomatology."3.73Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. ( Ardau, R; Chillotti, C; De Lisa, R; Del Zompo, M; Severino, G, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Severino, G1
Chillotti, C1
De Lisa, R1
Del Zompo, M1
Ardau, R1

Other Studies

1 other study available for lansoprazole and Gastrointestinal Stromal Neoplasm

ArticleYear
Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antineoplastic Agents; Benzamides; Drug Eruptions; Edema; F

2005